Elafibranor Patent Expiration
Elafibranor was first introduced by Ipsen Biopharmaceuticals Inc
Elafibranor Patents
Given below is the list of patents protecting Elafibranor, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Iqirvo | US11185519 | Methods of treatment of cholestatic diseases | Mar 30, 2037 | Ipsen |
| Iqirvo | US11331292 | Methods of treatment of cholestatic diseases | Mar 30, 2037 | Ipsen |
| Iqirvo | US11850223 | Methods of treatment of cholestatic diseases | Mar 30, 2037 | Ipsen |
| Iqirvo | US11857523 | Methods of treatment of cholestatic diseases | Mar 30, 2037 | Ipsen |
| Iqirvo | US7632870 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | Sep 09, 2024 | Ipsen |
| Iqirvo | US7943661 | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | Sep 09, 2024 | Ipsen |